The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Seasonal Influenza Vaccines Therapeutics Market Research Report 2024
Synopsis
Seasonal influenza vaccines are medical products used to prevent influenza virus infection and reduce the severity of flu symptoms during flu seasons.
The global Seasonal Influenza Vaccines Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The market for seasonal influenza vaccines is driven by the demand for preventive healthcare measures and the need to reduce the burden of seasonal flu on healthcare systems. The market's growth is also influenced by the growing emphasis on vaccination and immunization programs globally.
This report aims to provide a comprehensive presentation of the global market for Seasonal Influenza Vaccines Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Seasonal Influenza Vaccines Therapeutics.
Report Scope
The Seasonal Influenza Vaccines Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Seasonal Influenza Vaccines Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Seasonal Influenza Vaccines Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
Novartis
CSL
MedImmune
Sanofi-Pasteur
Solvay
Hualan Biological Engineering
Sinovac Biotech
Changchun Institute of Biological Products Co., Ltd.
Shanghai Institute of Biological Products Co., Ltd.
Segment by Type
Paediatrics
Adolescence
Adults
Elderly
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Seasonal Influenza Vaccines Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Seasonal influenza vaccines are medical products used to prevent influenza virus infection and reduce the severity of flu symptoms during flu seasons.
The global Seasonal Influenza Vaccines Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The market for seasonal influenza vaccines is driven by the demand for preventive healthcare measures and the need to reduce the burden of seasonal flu on healthcare systems. The market's growth is also influenced by the growing emphasis on vaccination and immunization programs globally.
This report aims to provide a comprehensive presentation of the global market for Seasonal Influenza Vaccines Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Seasonal Influenza Vaccines Therapeutics.
Report Scope
The Seasonal Influenza Vaccines Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Seasonal Influenza Vaccines Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Seasonal Influenza Vaccines Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
Novartis
CSL
MedImmune
Sanofi-Pasteur
Solvay
Hualan Biological Engineering
Sinovac Biotech
Changchun Institute of Biological Products Co., Ltd.
Shanghai Institute of Biological Products Co., Ltd.
Segment by Type
Paediatrics
Adolescence
Adults
Elderly
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Seasonal Influenza Vaccines Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Seasonal Influenza Vaccines Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Paediatrics
1.2.3 Adolescence
1.2.4 Adults
1.2.5 Elderly
1.3 Market by Application
1.3.1 Global Seasonal Influenza Vaccines Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Seasonal Influenza Vaccines Therapeutics Market Perspective (2019-2030)
2.2 Seasonal Influenza Vaccines Therapeutics Growth Trends by Region
2.2.1 Global Seasonal Influenza Vaccines Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Seasonal Influenza Vaccines Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Seasonal Influenza Vaccines Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Seasonal Influenza Vaccines Therapeutics Market Dynamics
2.3.1 Seasonal Influenza Vaccines Therapeutics Industry Trends
2.3.2 Seasonal Influenza Vaccines Therapeutics Market Drivers
2.3.3 Seasonal Influenza Vaccines Therapeutics Market Challenges
2.3.4 Seasonal Influenza Vaccines Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Seasonal Influenza Vaccines Therapeutics Players by Revenue
3.1.1 Global Top Seasonal Influenza Vaccines Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Seasonal Influenza Vaccines Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Seasonal Influenza Vaccines Therapeutics Revenue
3.4 Global Seasonal Influenza Vaccines Therapeutics Market Concentration Ratio
3.4.1 Global Seasonal Influenza Vaccines Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Seasonal Influenza Vaccines Therapeutics Revenue in 2023
3.5 Seasonal Influenza Vaccines Therapeutics Key Players Head office and Area Served
3.6 Key Players Seasonal Influenza Vaccines Therapeutics Product Solution and Service
3.7 Date of Enter into Seasonal Influenza Vaccines Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Seasonal Influenza Vaccines Therapeutics Breakdown Data by Type
4.1 Global Seasonal Influenza Vaccines Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Seasonal Influenza Vaccines Therapeutics Forecasted Market Size by Type (2025-2030)
5 Seasonal Influenza Vaccines Therapeutics Breakdown Data by Application
5.1 Global Seasonal Influenza Vaccines Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Seasonal Influenza Vaccines Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Seasonal Influenza Vaccines Therapeutics Market Size (2019-2030)
6.2 North America Seasonal Influenza Vaccines Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2019-2024)
6.4 North America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Seasonal Influenza Vaccines Therapeutics Market Size (2019-2030)
7.2 Europe Seasonal Influenza Vaccines Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Country (2019-2024)
7.4 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Seasonal Influenza Vaccines Therapeutics Market Size (2019-2030)
9.2 Latin America Seasonal Influenza Vaccines Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Detail
11.1.2 GSK Business Overview
11.1.3 GSK Seasonal Influenza Vaccines Therapeutics Introduction
11.1.4 GSK Revenue in Seasonal Influenza Vaccines Therapeutics Business (2019-2024)
11.1.5 GSK Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Seasonal Influenza Vaccines Therapeutics Introduction
11.2.4 Novartis Revenue in Seasonal Influenza Vaccines Therapeutics Business (2019-2024)
11.2.5 Novartis Recent Development
11.3 CSL
11.3.1 CSL Company Detail
11.3.2 CSL Business Overview
11.3.3 CSL Seasonal Influenza Vaccines Therapeutics Introduction
11.3.4 CSL Revenue in Seasonal Influenza Vaccines Therapeutics Business (2019-2024)
11.3.5 CSL Recent Development
11.4 MedImmune
11.4.1 MedImmune Company Detail
11.4.2 MedImmune Business Overview
11.4.3 MedImmune Seasonal Influenza Vaccines Therapeutics Introduction
11.4.4 MedImmune Revenue in Seasonal Influenza Vaccines Therapeutics Business (2019-2024)
11.4.5 MedImmune Recent Development
11.5 Sanofi-Pasteur
11.5.1 Sanofi-Pasteur Company Detail
11.5.2 Sanofi-Pasteur Business Overview
11.5.3 Sanofi-Pasteur Seasonal Influenza Vaccines Therapeutics Introduction
11.5.4 Sanofi-Pasteur Revenue in Seasonal Influenza Vaccines Therapeutics Business (2019-2024)
11.5.5 Sanofi-Pasteur Recent Development
11.6 Solvay
11.6.1 Solvay Company Detail
11.6.2 Solvay Business Overview
11.6.3 Solvay Seasonal Influenza Vaccines Therapeutics Introduction
11.6.4 Solvay Revenue in Seasonal Influenza Vaccines Therapeutics Business (2019-2024)
11.6.5 Solvay Recent Development
11.7 Hualan Biological Engineering
11.7.1 Hualan Biological Engineering Company Detail
11.7.2 Hualan Biological Engineering Business Overview
11.7.3 Hualan Biological Engineering Seasonal Influenza Vaccines Therapeutics Introduction
11.7.4 Hualan Biological Engineering Revenue in Seasonal Influenza Vaccines Therapeutics Business (2019-2024)
11.7.5 Hualan Biological Engineering Recent Development
11.8 Sinovac Biotech
11.8.1 Sinovac Biotech Company Detail
11.8.2 Sinovac Biotech Business Overview
11.8.3 Sinovac Biotech Seasonal Influenza Vaccines Therapeutics Introduction
11.8.4 Sinovac Biotech Revenue in Seasonal Influenza Vaccines Therapeutics Business (2019-2024)
11.8.5 Sinovac Biotech Recent Development
11.9 Changchun Institute of Biological Products Co., Ltd.
11.9.1 Changchun Institute of Biological Products Co., Ltd. Company Detail
11.9.2 Changchun Institute of Biological Products Co., Ltd. Business Overview
11.9.3 Changchun Institute of Biological Products Co., Ltd. Seasonal Influenza Vaccines Therapeutics Introduction
11.9.4 Changchun Institute of Biological Products Co., Ltd. Revenue in Seasonal Influenza Vaccines Therapeutics Business (2019-2024)
11.9.5 Changchun Institute of Biological Products Co., Ltd. Recent Development
11.10 Shanghai Institute of Biological Products Co., Ltd.
11.10.1 Shanghai Institute of Biological Products Co., Ltd. Company Detail
11.10.2 Shanghai Institute of Biological Products Co., Ltd. Business Overview
11.10.3 Shanghai Institute of Biological Products Co., Ltd. Seasonal Influenza Vaccines Therapeutics Introduction
11.10.4 Shanghai Institute of Biological Products Co., Ltd. Revenue in Seasonal Influenza Vaccines Therapeutics Business (2019-2024)
11.10.5 Shanghai Institute of Biological Products Co., Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
